Life sciences news
-
X-Pure®–by-design : Antleron-Rousselot® collaborative-development partnership
Tuesday October 12th 2021
Read more
-
KU Leuven develops very potent antiviral against dengue
Thursday October 7th 2021
Read more
-
Precirix dosed first patients in Phase I/II clinical study evaluating CAM-H2 in HER2-positive metastatic cancer
Wednesday October 6th 2021
Read more
-
atbtherapeutics expands leadership team and Scientific Advisory Board with pharmaceutical industry experts
Wednesday October 6th 2021
Read more
-
New Flanders360 platform puts Flanders’ life sciences & health ecosystem on the international map
Tuesday October 5th 2021
Read more
-
Second edition Medical Solutions Accelerator starts successfully
Monday October 4th 2021
Read more
-
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
Monday October 4th 2021
Read more
-
Sequana Medical announces FDA approval to expand patient enrolment in North American pivotal alfapump® study (POSEIDON)
Monday October 4th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
S-Biomedic announces completion of prestigious financing with European Innovation Council Fund
Friday October 1st 2021
Read more
-
Biotalys strengthens executive team with the appointment of Patrick McDonnell as Chief Business Officer
Thursday September 30th 2021
Read more
-
OXURION announces positive results from Part A of Phase 2 Study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)
Thursday September 30th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
